Skip to main content

Table 2 Distribution of presenting symptoms at the time of radiation therapy

From: Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: a retrospective cohort study

Domain Number of cases Percent of all cases* Median duration (months)** Prior surgery New symptom post-op***
Visual Acuity/Visual Field 129 57.6% 12.8 51.9% 0.8%
Any Diplopia/Ptosis 75 33.5% 9.9 41.3% 2.7%
  Cranial Nerve III 37 16.5%
  Cranial Nerve IV 8 3.6%
  Cranial Nerve VI 39 17.4%
  Unspecified 20 8.9%
Facial Sensation 50 22.3% 9.9 50.0% 18.0%
Facial Weakness 12 5.4% 8.4 91.7% 50.0%
Hearing 34 15.2% 13.6 50.0% 17.6%
Balance 32 14.3% 12.9 43.8% 6.3%
Tinnitus 7 3.1% 26.4 28.6% 0
Cranial Nerve IX -XII 8 3.6% 14.7 100% 37.5%
Other 61 27.2% 9.7 45.9% 3.3%
Asymptomatic 19 8.5% -- 47.4% --
  1. * Do not add up to 100% because some patient presented with multiple symptoms.
  2. **Duration of symptom prior to radiation therapy.
  3. ***Among cases with the specific deficit at radiation, percent where the symptom only appeared in the post-operative setting.